Professional ICO Analytics
Professional ICO Analytics

ClinTex (CLX)

Main information

Official site: 

https://www.clintex.io

Bounty: 

Pre ICO date: 

N/A

ICO date: 

N/A

Status: 

Upcoming

Weighted Average Rating: 

67.29

Project area: 

Health

Product: 

Distributed ledger technology platform for the clinical trials industry, which uniquely provides an end to end decentralised solution that incorporates tools to drive significant quality and operational improvements in running Clinical Trials through advanced clinical data review, insightful operational KPIs, predictive data analytics and machine learning (AI).

MVP: 

Country: 

Malta

KYC Verification: 

Where can be used: 

At decreasing the cost of medicine and increasing the speed to market and access to new medicines for people who need it.

Rating agencies: 

ICOmarks6.9/10

Blockchain information

Token type: 

ERC20

Platform type: 

Ethereum

People

Team: 

NamePrevious companiesLinks
Adrian W. DonoghueDataPharm, Q-Tel Srl, Consultant Technologies
Dr. Samandip DhesiIntellimed, The Royal Wolverhampton NHS Trust, Whitecoat Mentors
John McCabeMaguire Bardon Solicitors, Cian O'Carroll Solicitors
Edward BurkeCiti, Wayfair, Paddy Power Betfair
Stanislav SheliakinApplicature, fluence.sh
Ethan DiamantPAREXEL, GlaxoSmithKline, SmithKline Beecham
Sean FlanaganBarclays Bank Ireland PLC, Axemart Limited, National Australia Bank
Philip O’Neill
Graham StoneIBC Group - International Blockchain Consulting, Hicky, Upwork

Advisors: 

NamePrevious companiesLinks
Dr. Sheraz MajeedJWC Blockchain Ventures
Binod NirvanMixERP, CYBR - Cyber Security Ecosystem and Utility Token, MOOVIN
Stefan Bergström
Sean ComiskeyBanach Technology Ltd, Sportsbet.com.au, Connect Develop Pty Ltd
Ihor PidruchnyApplicature, fluence.sh, ReMoneta
Dr. Omar ZerafaZerafa Advocates, Financial Services Law Firm, Aequitas Legal

Partners: 

Zerafa Advocates Sum & Substance

Financial details

Total token vol: 

Token in ICO: 

50

PreICO value: 

1 CLX = 0.08 USD

ICO value: 

1 CLX = 0.10 USD

Token Distribution: 

  • Token Generation Event : 35%
  • Token Generation Event Pre-Sale : 15%
  • Strategic Partners Private Sale : 10%
  • Management Team : 10%
  • Shareholders : 10%
  • Team Incentive (Milestone Based Structured Bonus Scheme) : 10%
  • Advisors : 4%
  • Referrals, Promotions & Bounty : 3%
  • Pharma Industrial Trials (Testing) : 3%

Fund usage: 

  • Platform development : 35%
  • Clinical and analytic development : 30%
  • Marketing & sales, business growth and development : 15%
  • Legal and accounting expenses : 10%
  • Operational expenses : 8%
  • ClinTex research grants : 2%

Hardcap: 

17000000 USD

Softcap: 

4000000 USD

Attracted: 

Attracted %: 

Road map

What is done: 

Q2 2018 CTi Data Model Design; CTi-OEM Prototype Development. Q3 2018 Pre Sale TGE; Public TGE. Q4 2018 CTi GUI Development (with Integrated CLX Wallet); Blockchain Verification of CTi Pre-Processing Data.

What is planned: 

Q1 2019 Blockchain Verification of CTi Pre-Processing Data; CTi-OEM DEvelopment.Q2 2019CTi-PDA Development. Q3 2019 CTi-PRR Development; Migration on-chain of CTiClinical Data Statistical Summaries. Q4 2019 CTi-RBM Development; CTi-CDV Development. Q1 2020 Cti-VMM Development. Q2 2020 CTi-SIM Development. Q3-Q4 2020 Migration on-chain of the CTi Data Model and CTi Processing Engine.

Road map progress: 

35%